Repligen Corp leadership
Snapshot
Repligen Corp's leadership comprises 9 directors and 6 named executive officers, led by Olivier Loeillot (President and Chief Executive Officer, Director). Names, tenure and backgrounds are sourced from the latest SEC proxy statement (DEF 14A).
- Board size
- 9
- Source
- Proxy statement
Board & leadership
President and CEO of Repligen; joined October 2023 as President and Chief Commercial Officer; former CEO of Ascensus Specialties and Bioprocess President at Cytiva.
View full profileChair of the Repligen Board since March 2026; senior operating executive at The Carlyle Group; former Chairman, President and CEO of Millipore.
View full profilePresident of Knowledgeable Decisions, LLC; former Lead Independent Director of Repligen; former SVP at Bayer and Wyeth.
View full profileSenior Advisor at Warburg Pincus since 2020; former President and CEO of bioTheranostics; former President, Global Commercial Operations at Life Technologies.
View full profilePresident and CEO of OraSure Technologies since 2022; former SVP at Quest Diagnostics; two decades at GE Healthcare.
View full profileChief Technology Officer at Ring Therapeutics and Operating Partner at Flagship Pioneering; former CTO at Codiak BioSciences.
View full profileExecutive Vice President and Chief Technical Operations Officer at Parabilis Medicines (formerly FogPharma); 27 years at Biogen.
View full profileRetired CFO and Executive Vice President of Hologic, Inc.; 26 years with Hologic.
View full profileFormer Vice President, Strategy and Innovation at Thermo Fisher Scientific; over 30 years in life sciences growth strategy.
View full profileCFO of Repligen since September 2023; former EVP and CFO of Integer Holdings; ~20 years at General Electric.
View full profileCOO of Repligen since January 2022; joined March 2020 as SVP, Global Operations and IT; ten years at Thermo Fisher.
View full profileSVP, R&D at Repligen since October 2016; former VP at Pall Corporation's Life Sciences single-use business unit.
View full profileSVP and Chief Product Officer of Repligen since December 2025; joined May 2024 as SVP, Filtration and Chromatography; former VP/GM at Thermo Fisher.
View full profileChief Accounting Officer and principal accounting officer of Repligen, effective September 1, 2025; former Chief Accounting Officer at Azenta.
View full profileDeparting Executive Chair of the Board; former Chief Executive Officer of Repligen; retired from the Board effective March 13, 2026.
View full profile